Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × camrelizumab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Nasopharyngeal Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 9 fludarabine phosphate 5 fludarabine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 Vincristine 3 Vinblastine 3 Rituximab 3 Prednisone 3 Nivolumab 3 Gemcitabine 3 Dacarbazine 3 Bleomycin 3 pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Cisplatin 2 Brentuximab Vedotin 2 Blood Specimen Collection 2 treosulfan 1 tislelizumab 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡